Literature DB >> 31127462

Evaluation of left and right ventricle by two-dimensional speckle tracking echocardiography in systemic sclerosis patients without overt cardiac disease.

Duygu Temiz Karadag1, Tayfun Sahin2, Senem Tekeoglu3, Ozlem Ozdemir Işik3, Ayten Yazici3, Fatma Ceyla Eraldemir4, Ayse Cefle3.   

Abstract

BACKGROUND/
OBJECTIVE: The aim was to evaluate the left and right ventricular functions concurrently by two-dimensional speckle tracking echocardiography (STE) in systemic sclerosis (SSc) patients without overt cardiac disease.
METHODS: A total of 47 patients with SSc and 36 age- and sex-matched controls were evaluated cross-sectionally. Two-dimensional STE was used to assess the longitudinal peak systolic strains (PSS) of both ventricles including apical long-axis (APLAX), apical four-chamber (4-CH), apical two-chamber (2-CH), and global longitudinal measurements. Any association of metabolic, cardiac, and inflammatory biomarkers with PSS was investigated.
RESULTS: The longitudinal PSS of the left ventricle [APLAX, 4-CH, 2-CH and global] were significantly lower in SSc patients than controls (- 18.2 ± 3.2 vs - 19.8 ± 2.7% p = 0.02; - 17.8 ± 3.5 vs. - 20.3 ± 3.3% p = 0.001; - 18.6 ± 3.1 vs. - 21.8 ± 3% p < 0.001; - 17.5 ± 5.7 vs. - 20.6 ± 2.7% p = 0.003, respectively). No difference was found between the groups for right ventricular strains. The longitudinal PSS-4CH correlated positively with CRP and ESR (r = 0.349, p = 0.016; r = 0.356, p = 0.014, respectively) and negatively with serum Galectin-3 (r = - 0.362, p = 0.012). Global longitudinal PSS-left ventricle (LV) correlated positively with CRP and homocysteine (r = 0.297, p = 0.043; r = 0.313, p = 0.041, respectively) and negatively with serum Galectin-3 (r = -0.314, p = 0.041). After multivariable adjustment, CRP remained the only predictor of longitudinal PSS-4CH (95% CI 0.35, 0.70, p = 0.028) and global longitudinal PSS of left ventricle (95% CI 0.004, 0.22, p = 0.043).
CONCLUSIONS: Biventricular evaluation of patients with SSc by two dimensional STE revealed reduced left ventricular longitudinal strains, despite preserved right ventricular strain, and no diastolic dysfunction. In SSc without overt cardiac disease, global cardiac assessment with 2DSTE is a promising method which seems to contribute to the detection of patients without clinical findings. KEY POINTS: • Two dimensional STE revealed reduced left ventricular longitudinal strains, despite preserved right ventricular strain in SSc patients without overt cardiac disease. • CRP was the predictor of decreased longitudinal strains. • Cardiac assessment in SSc should be made globally.

Entities:  

Keywords:  Left ventricle; Right ventricle; Speckle tracking echocardiography; Systemic sclerosis; Systolic dysfunction

Year:  2019        PMID: 31127462     DOI: 10.1007/s10067-019-04604-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

Review 1.  Assessment of disease severity and prognosis.

Authors:  T A Medsger; S Bombardieri; L Czirjak; R Scorza; A Della Rossa; W Bencivelli
Journal:  Clin Exp Rheumatol       Date:  2003       Impact factor: 4.473

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa
Journal:  Eur J Echocardiogr       Date:  2009-03

3.  Guidelines for the use of echocardiography as a monitor for therapeutic intervention in adults: a report from the American Society of Echocardiography.

Authors:  Thomas R Porter; Sasha K Shillcutt; Mark S Adams; Georges Desjardins; Kathryn E Glas; Joan J Olson; Richard W Troughton
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

4.  Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and Fibrosis: Implications for Its Use as a Biomarker.

Authors:  Christian Besler; David Lang; Daniel Urban; Karl-Philipp Rommel; Maximilian von Roeder; Karl Fengler; Stephan Blazek; Reinhard Kandolf; Karin Klingel; Holger Thiele; Axel Linke; Gerhard Schuler; Volker Adams; Philipp Lurz
Journal:  Circ Heart Fail       Date:  2017-03       Impact factor: 8.790

Review 5.  Cardiac manifestations in systemic sclerosis.

Authors:  Sevdalina Lambova
Journal:  World J Cardiol       Date:  2014-09-26

6.  Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis.

Authors:  P de Groote; V Gressin; E Hachulla; P Carpentier; L Guillevin; A Kahan; J Cabane; C Francès; N Lamblin; E Diot; F Patat; J Sibilia; H Petit; J-L Cracowski; P Clerson; M Humbert
Journal:  Ann Rheum Dis       Date:  2007-01-31       Impact factor: 19.103

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

8.  Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.

Authors:  Vivien M Hsu; Abel E Moreyra; Alan C Wilson; Meir Shinnar; Daniel M Shindler; Julianne E Wilson; Ami Desai; James R Seibold
Journal:  J Rheumatol       Date:  2008-01-15       Impact factor: 4.666

9.  Impaired myocardial deformation in psoriatic arthritis patients assessment by speckle tracking echocardiography.

Authors:  B Yilmazer; T Sahin; A Cefle
Journal:  Acta Reumatol Port       Date:  2016 Apr-Jun       Impact factor: 1.290

10.  Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis.

Authors:  Monique Hinchcliff; Chintan S Desai; John Varga; Sanjiv J Shah
Journal:  Clin Exp Rheumatol       Date:  2012-05-29       Impact factor: 4.473

View more
  4 in total

1.  Speckle tracking echocardiography in systemic sclerosis: how far have we arrived and where can we go.

Authors:  Giulia Stronati; Federico Guerra; Armando Gabrielli; Alessandro Capucci
Journal:  Clin Rheumatol       Date:  2019-10-03       Impact factor: 2.980

2.  Application Effect and Evaluation of Two-Dimensional Speckle Tracking Imaging on Myocardial Damage in Patients with Malignant Lymphoma Treated with Anthracyclines.

Authors:  Chunqiang Bai; Fanyue Meng; Peiming Feng; Wan Wang; Liang Fang; Qiankun Chang; Lihong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

3.  Diagnosis of Simultaneous Atrial and Ventricular Mechanical Performance in Patients with Systemic Sclerosis.

Authors:  Mohammadbagher Sharifkazemi; Mohammadali Nazarinia; Alireza Arjangzade; Mohamad Goldust; Zahra Hooshanginezhad
Journal:  Biology (Basel)       Date:  2022-02-14

Review 4.  Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.

Authors:  Peter Glynn; Sarah Hale; Tasmeen Hussain; Benjamin H Freed
Journal:  Front Cardiovasc Med       Date:  2022-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.